A recent study, published in the Archives of Internal Medicine, found that the cholesterol-lowering drugs known as statins increase the risk of diabetes within postmenopausal women by 48%.
This new finding adds to a growing body of clinical evidence that statin drugs are fundamentally diabetogenic, which is not surprising considering the National Library of Medicine contains peer-reviewed, published research on over 300 other known adverse effects associated with their use.
Following in the wake of new U.S. guidelines that will require 70 million Americans take statin drugs, new research finds they increase the risk of herpest zoster (shingles), adding to the over 300 adverse health effects linked to this drug class.
As we age, mitochondrial density (the number of mitochondria per cell), and mitochondrial quality (its genetic and structural integrity) decline. This is largely due to stress, environmental radiation and chemical exposures, prescribed drugs, nutritional deficiencies, imbalances and/or incompatibilities, and mitochondrial DNA defects inherited maternally, but is also a natural part of getting older.